CIK 0000727510 · Biological Products, (No Diagnostic Substances) (SIC 2836) · OTC · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 26000 | 26000 | 701000 | |
| Net income (USD) | -3.4 M | 1.4 M | -186000 | |
| Diluted EPS (USD/shares) | -0.07 | 0 | -0.02 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-08-03 | 10-Q | 10-Q | 2026-06-30 |
| 2026-05-05 | 8-A12G | 8-A12G | |
| 2026-05-05 | 8-K | FORM 8-K items 1.01,3.03,5.03,7.01,9.01 | 2026-04-30 |
| 2026-05-04 | 10-Q | 10-Q | 2026-03-31 |
| 2026-05-01 | 3 | OWNERSHIP DOCUMENT | 2026-04-30 |
| 2026-05-01 | 8-K/A | FORM 8-K/A items 9.01 | 2026-03-26 |
| 2026-05-01 | 8-K | FORM 8-K items 5.02 | 2026-04-29 |
| 2026-04-29 | 10-K/A | 10-K/A | 2025-12-31 |
| 2026-04-21 | 8-K | FORM 8-K items 1.01,2.03,9.01 | 2026-04-16 |
| 2026-04-16 | 8-K | FORM 8-K items 4.01,9.01 | 2026-04-14 |
| 2026-04-15 | 8-K | FORM 8-K items 5.02 | 2026-04-10 |
| 2026-03-27 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2026-03-25 |
| 2026-03-27 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-03-26 | 3 | OWNERSHIP DOCUMENT | 2026-03-26 |
| 2026-03-26 | 3 | OWNERSHIP DOCUMENT | 2026-03-26 |
| 2026-03-26 | 3 | OWNERSHIP DOCUMENT | 2026-03-26 |
| 2026-03-26 | 3 | OWNERSHIP DOCUMENT | 2026-03-26 |
| 2026-03-26 | 3 | OWNERSHIP DOCUMENT | 2026-03-26 |
| 2026-03-26 | 3 | OWNERSHIP DOCUMENT | 2026-03-26 |
| 2026-03-26 | 3 | OWNERSHIP DOCUMENT | 2026-03-26 |
| 2026-03-26 | 3 | OWNERSHIP DOCUMENT | 2026-03-26 |
| 2026-03-26 | 3 | OWNERSHIP DOCUMENT | 2026-03-26 |
| 2026-03-26 | 3 | OWNERSHIP DOCUMENT | 2026-03-26 |
| 2026-03-26 | 3 | OWNERSHIP DOCUMENT | 2026-03-26 |
| 2026-03-26 | 3 | OWNERSHIP DOCUMENT | 2026-03-26 |
Forms on file (last 1,000): 4 285, 8-K 200, SC 13G/A 71, 10-Q 66, 3 51, SC 13D/A 41, SC 13G 39, DEFA14A 23. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=VISK (0.002 USD), /gw/filings/filings?ticker=VISK&form=8-K, /gw/filings/facts?ticker=VISK&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange